ÂÒÂ×С¿É°®

M. Cathleen Kaveny is the Darald and Juliet Libby Professor of ÂÒÂ×С¿É°®, a position that includes appointments in the department of theology and law school. Kaveny previously held the position of John P. Murphy Foundation Professor of Law and Theology at Notre Dame Law School. Kaveny has published over forty articles and essays in journals and books specializing in law, ethics, and medical ethics. She has served on several editor boards, including the American Journal of Jurisprudence, the Journal of Religious Ethics, the Journal of Law and Religion, and the Journal of the Society of Christian Ethics. In the media, her accomplishments include combining research and religion into the curriculum of her ethics seminars, speaking at a Vatican conference in 2001 and meeting with Cardinal Rratzinger in 2005. On March 1, 2012, Kaveny was the guest on The Daily Show with Jon Stewart where she discussed the legal and theological issues surrounding the Catholic Church's position on contraception. She is a blogger and columnist for Commonweal magazine, an online journal that publishes editorials, columns, essays and poetry as well as both film and book reviews. She earned an A.B. from Princeton University and an M.A., M. Phil., J.D. and Ph.D. from Yale University.

John LaMattina is a senior partner at PureTech Ventures. He is a former senior vice president at Pfizer and president of Pfizer Global Research and Development Pharmaceuticals. During his tenure as head of Global R&D, Pfizer produced new treatments for cancer, smoking cessation, rheumatoid arthritis and AIDS. LaMattina is the author of numerous scientific publications and holds a number of U.S. patents. He is also the author of Drug Truths: Dispelling the Myths About Pharma R&DÌý²¹²Ô»åÌýDevalued and Distrusted–Can the Pharmaceutical Industry Restore Its Broken Image?, and a contributor to Forbes.com. LaMattina graduated from ÂÒÂ×С¿É°® with a B.S. in Chemistry and received his Ph.D. in Organic Chemistry from the University of New Hampshire.

Peter Markell is currently executive vice-president of administration and finance, CFO & treasurer at Partners HealthCare Systems. Markell leads a number of strategic efforts aimed towards care redesign and patient affordability. Prior to his positions at Partners, he was a partner at Ernst and Young, where he was responsible for a variety of activities including mergers and acquisitions, financial strategies, taxes, Securities and Exchange Commission filings and interactions, and restructuring account executive expenditures. In his role as partner, Markell was in charge of Human Resources and Administration, including the management of the merger and consolidation of Ernst & Whinney and Arthur Young in New England. Markell is a Certified Public Accountant and earned his B.S.and B.A. with concentrations in Accounting and Finance from ÂÒÂ×С¿É°®.

Eric H. Schultz is president and chief executive officer of Harvard Pilgrim Health Care. During his 26-year career in health care, Schultz has aimed to define and implement changes that have led to improvements and greater efficiencies in both the cost and delivery of health care. Prior to joining Harvard Pilgrim, Schultz was president and chief executive officer of Fallon Community Health Plan. He has also held executive positions with CIGNA Healthcare, where he oversaw plan operations for Eastern Missouri and Southern Illinois, and with Prudential Healthcare where he led its Nashville and Memphis commercial and Medicaid business. He has served as medical group administrator for Nashville Healthcare Group and was responsible for building a clinical delivery site for Nashville’s largest primary care group practice. Schultz holds an MBA in Health Care Leadership from Yale University’s School of Management, as well as a B.S. in biology and a B.A. in economics from the University of Connecticut.